NIC provides a ground breaking nanotechnology designed to contribute towards improving the solubility and bioavailability of hydrophobic bioactive ingredients including non-storied anti-inflammatory drugs (NSAID), cannabinoids and lipophilic nutraceuticals. Based on more than 10 years of research on advanced drug delivery systems, we provide IP-protected smart solutions to develop water-soluble, highly bioavailable and controlled release products in liquid, gel and powder dosage forms for pharmaceutical, nutraceutical and cosmetic applications.

Team Members

Mehdi Nouraei
Founder & CEO

Edgar Acosta
Sr. Scientific Advisor